Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study

被引：0

作者：

Vermeire, S. ^{[1
]}

Colombel, J. F. ^{[2
]}

Rubin, D. T. ^{[3
]}

Ghosh, S. ^{[4
]}

Jain, A. ^{[5
]}

Lawlor, G. ^{[5
]}

Osterman, M. T. ^{[5
]}

Wu, H. ^{[5
]}

Canavan, J. B. ^{[5
]}

Chiorean, M. V. ^{[6
]}

机构：

[1] Univ Leuven, Chron Dis & Metab, Leuven, Belgium

[2] Icahn Sch Med Mt Sinai, Gastroenterol, New York, NY USA

[3] Univ Chicago Med, Gastroenterol, Inflammatory Bowel Dis Ctr, Chicago, IL USA

[4] Univ Birmingham Birmingham, Immunol & Immunotherapy, Birmingham, W Midlands, England

[5] Bristol Myers Squibb, Clin Res, Princeton, NJ USA

[6] Swedish Gastroenterol, Gastroenterol, Issaquah, WA USA

来源：

JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P715

引用

页码：844 / 845

页数：2

共 36 条

[11] Durability of Symptomatic and Clinical Outcomes in Ozanimod- Treated Patients by Endpoints of Increasing Objectivity at True North Week 52: Interim Analysis of the True North Open-Label Extension Study [J].

Abreu, Maria T. ;

Panaccione, Remo ;

Vermeire, Severine ;

Rubin, David T. ;

Mehra, Dimpy ;

Wu, Hsiuanlin ;

Osterman, Mark T. ;

Ahmad, Harris A. ;

Jain, Anjali ;

Danese, Silvio .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10) :S698-S699

[12] Delayed Response to Ozanimod in Patients with Moderate vs Severe Endoscopic Disease: 4-Year Interim Analysis of the True North Open-Label Extension Study [J].

Wolf, Douglas C. ;

Cross, Raymond K. ;

Ritter, Timothy E. ;

Stallmach, Andreas ;

Hindryckx, Pieter ;

Chang, Shannon ;

Tharmarajah, Soba ;

Wu, Hsiuanlin ;

Osterman, Mark T. ;

Jain, Anjali ;

Irving, Peter M. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) :S1035-S1035

[13] Efficacy and safety of 3 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study [J].

Danese, S. ;

Abreu, M. T. ;

Wolf, D. C. ;

Canavan, J. B. ;

Jain, A. ;

Wu, H. ;

Petersen, A. ;

Charles, L. ;

Panaccione, R. ;

Afzali, A. .

JOURNAL OF CROHNS & COLITIS, 2023, 17 :I101-I102

[14] Efficacy and safety of 3 years of continuous ozanimod treatment: An interim analysis of the True North open-label extension study [J].

Danese, S. ;

Sparrow, M. ;

Abreu, M. T. ;

Wolf, D. C. ;

Canavan, J. B. ;

Jain, A. ;

Wu, H. ;

Petersen, A. ;

Charles, L. ;

Panaccione, R. ;

Afzali, A. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 :121-122

[15] Efficacy and safety of 4 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study [J].

D'Haens, G. ;

Sands, B. E. ;

Ferrante, M. ;

Matsuoka, K. ;

Lindsay, J. O. ;

Blumenstein, I. ;

Mehra, D. ;

Charles, L. ;

Cetin, V. ;

Petersen, A. ;

Wu, H. ;

Wang, D. ;

Jain, A. ;

Hanauer, S. B. .

JOURNAL OF CROHNS & COLITIS, 2024, 18 :I1814-I1815

[16] Extended induction in the True North open-label extension study: Ozanimod efficacy in biologic-naive and biologic-experienced patients [J].

Dignass, A. ;

Sparrow, M. ;

Regueiro, M. ;

Colombel, J-F ;

Jain, A. ;

Canavan, J. B. ;

Wu, H. ;

Lawlor, G. ;

Osterman, M. T. ;

Vermeire, S. ;

Rubin, D. T. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 :120-121

[17] EFFECT OF LURASIDONE ON COGNITION IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY [J].

Harvey, Philip D. ;

Goldman, Robert ;

Tocco, Michael ;

Deng, Ling ;

Cucchiaro, Josephine ;

Loebel, Antony .

SCHIZOPHRENIA BULLETIN, 2018, 44 :S353-S353

[18] Sustained Efficacy and Safety After 5 Years of Continuous Ozanimod Treatment Independent of Clinical Remission Status: An Interim Analysis of the True North Open-Label Extension Study [J].

Cross, Raymond K. ;

Danese, Silvio ;

Wolf, Douglas C. ;

Matsuoka, Katsuyoshi ;

Dotan, Iris ;

Boland, Brigid S. ;

Raffals, Laura E. ;

Mehra, Dimpy ;

Santiago, Norma Ruiz ;

Petersen, AnnKatrin ;

Desai, Manik ;

Wu, Hsiuanlin ;

Wang, Dong ;

Osterman, Mark T. ;

Jain, Anjali ;

Lindsay, James O. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10) :S853-S854

[19] Sustained Efficacy and Safety After 5 Years of Continuous Ozanimod Treatment Independent of Clinical Remission Status: An Interim Analysis of the True North Open-Label Extension Study [J].

Cross, Raymond K. ;

Danese, Silvio ;

Wolf, Douglas C. ;

Matsuoka, Katsuyoshi ;

Dotan, Iris ;

Boland, Brigid S. ;

Raffals, Laura E. ;

Mehra, Dimpy ;

Santiago, Norma Ruiz ;

Petersen, Annkatrin ;

Desai, Manik ;

Wu, Hsiuanlin ;

Wang, Dong ;

Osterman, Mark T. ;

Jain, Anjali ;

Lindsay, James O. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) :S853-S854

[20] Effect of lurasidone on neurocognitive performance in children and adolescents with bipolar depression: interim analysis at week 52 of a 2-year open-label extension study [J].

Burdick, K. E. ;

Goldman, R. ;

Tocco, M. ;

Deng, L. ;

Cucchiaro, J. ;

Loebel, A. .

BIPOLAR DISORDERS, 2018, 20 :68-69

← 1 2 3 4 →